Zantac / Ranitidine (NDMA Cancer) Lawsuit in Louisiana

Preparing your case review…
Written By
People's Justice Legal Research Team

Statute of Limitations

Louisiana has a 1-year prescriptive period (statute of limitations) for delictual personal injury actions (La. Civ. Code art. 3492) — one of the two shortest limitation periods in the Zantac claimant pool alongside Tennessee. The discovery doctrine (contra non valentem) tolls the period until the claimant discovers the injury and its cause. Louisiana courts apply a Daubert-based standard for expert testimony under La. C.E. art. 702. Louisiana's 1-year deadline makes it one of the most time-sensitive states for Zantac cancer claimants — any delay risks permanent loss of claims.

1 year from date of cancer diagnosis discovery — MOST URGENT: act immediately (tied with Tennessee)

Louisiana Data

Exposure in Louisiana

Source: U.S. Census Bureau 2024

Source: Louisiana Tumor Registry 2024

Source: La. Civ. Code art. 3492

Medical Resources

Clinics & Specialists in Louisiana

LSU Health New Orleans — Feist-Weiller Cancer Center

Tulane Cancer Center

FAQ

Frequently Asked Questions

See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
See details below.
Back to Zantac / Ranitidine (NDMA Cancer) Lawsuit Overview